Plasma protein patterns as comprehensive indicators of health.
Journal
Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015
Informations de publication
Date de publication:
12 2019
12 2019
Historique:
received:
20
06
2019
accepted:
23
10
2019
pubmed:
4
12
2019
medline:
28
1
2020
entrez:
4
12
2019
Statut:
ppublish
Résumé
Proteins are effector molecules that mediate the functions of genes
Identifiants
pubmed: 31792462
doi: 10.1038/s41591-019-0665-2
pii: 10.1038/s41591-019-0665-2
pmc: PMC6922049
mid: NIHMS1062976
doi:
Substances chimiques
Blood Proteins
0
Types de publication
Journal Article
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1851-1857Subventions
Organisme : Medical Research Council
ID : MR/R024227/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : MC_UU_12015/1
Pays : United Kingdom
Organisme : NIA NIH HHS
ID : RF1 AG062553
Pays : United States
Organisme : Medical Research Council
ID : MR/S011676/1
Pays : United Kingdom
Organisme : NHLBI NIH HHS
ID : R01 HL146462
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG056477
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL045670
Pays : United States
Organisme : British Heart Foundation
ID : RG/10/12/28456
Pays : United Kingdom
Organisme : British Heart Foundation
ID : SP/13/6/30554
Pays : United Kingdom
Références
Sun, B. B. et al. Genomic atlas of the human plasma proteome. Nature 558, 73–79 (2018).
doi: 10.1038/s41586-018-0175-2
Emilsson, V. et al. Co-regulatory networks of human serum proteins link genetics to disease. Science 361, 769–773. (2018).
doi: 10.1126/science.aaq1327
Tasaki, S. et al. Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remission. Nat. Commun. 9, 2755 (2018).
doi: 10.1038/s41467-018-05044-4
O’Dwyer, D. N. et al. The peripheral blood proteome signature of idiopathic pulmonary fibrosis is distinct from normal and is associated with novel immunological processes. Sci. Rep. 7, 46560 (2017).
doi: 10.1038/srep46560
Christensson, A. et al. The impact of the glomerular filtration rate on the human plasma proteome. Proteom. Clin. Appl. 12, e1700067 (2018).
doi: 10.1002/prca.201700067
Ganz, P. et al. Development and validation of a protein-based risk score for cardiovascular outcomes among patients with stable coronary heart disease. J. Am. Med. Assoc. 315, 2532–2541 (2016).
doi: 10.1001/jama.2016.5951
Wood, G. C., Chu, X. & Argyropoulos, G. et al. A multi-component classifier for nonalcoholic fatty liver disease (NAFLD) based on genomic, proteomic, and phenomic data domains. Sci. Rep. 7, 43238 (2017).
doi: 10.1038/srep43238
Han, Z. et al. Validation of a novel modified aptamer-based array proteomic platform in patients with end-stage renal disease. Diagnostics (Basel) 8, 71 (2018).
Menni, C. et al. Circulating proteomic signatures of chronolological age. J. Gerontol. A 70, 809–816 (2014).
doi: 10.1093/gerona/glu121
Thrush, A. et al. Diet-resistant obesity is characterized by a distinct plasma proteomic signature and impaired muscle fiber metabolism. Int. J. Obes. 42, 353–362 (2018).
doi: 10.1038/ijo.2017.286
Williams, S. A. et al. Improving assessment of drug safety through proteomics: early detection and mechanistic characterization of the unforeseen harmful effects of torcetrapib. Circulation 137, 999–1010 (2018).
doi: 10.1161/CIRCULATIONAHA.117.028213
Rohloff, J. C. et al. Nucleic acid ligands with protein-like side chains: modified aptamers and their use as diagnostic and therapeutic agents. Mol. Ther. Nucleic Acids 3, e201 (2014).
doi: 10.1038/mtna.2014.49
Gold, L. et al. Aptamer-based multiplexed proteomic technology for biomarker discovery. PLoS ONE 5, e15004 (2010).
doi: 10.1371/journal.pone.0015004
Brody, E. et al. Life’s simple measures: unlocking the proteome. J. Mol. Biol. 422, 595–606 (2012).
doi: 10.1016/j.jmb.2012.06.021
Kim, C. H. et al. Stability and reproducibility of proteomic profiles measured with an aptamer-based platform. Sci. Rep. 8, 8382 (2018).
doi: 10.1038/s41598-018-26640-w
Candia, J. et al. Assessment of variability in the SOMAscan assay. Sci. Rep. 7, 14248 (2017).
doi: 10.1038/s41598-017-14755-5
Collaborators GBDRF, Forouzanfar, M. H. et al. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 386, 2287–2323 (2015).
doi: 10.1016/S0140-6736(15)00128-2
Maruthappu, M. Delivering triple prevention: a health system responsibility. Lancet Diabetes Endocrinol. 4, 299–301 (2016).
doi: 10.1016/S2213-8587(16)00073-5
Robson, J. et al. The NHS Health Check in England: an evaluation of the first 4 years. BMJ Open 6, e008840 (2016).
doi: 10.1136/bmjopen-2015-008840
Valabhji, J. et al. Efficacy and effectiveness of screen and treat policies in prevention of type 2 diabetes: systematic review and meta-analysis of screening tests and interventions. BMJ 356, i6538 (2017).
Middleton, K. R., Anton, S. D. & Perri, M. G. Long-term adherence to health behavior change. Am. J. Lifestyle Med. 7, 395–404 (2013).
doi: 10.1177/1559827613488867
Dimitrov, D. V. Medical internet of things and big data in healthcare. Health Inf. Res. 22, 156–163 (2016).
doi: 10.4258/hir.2016.22.3.156
Flores, M., Glusman, G., Brogaard, K., Price, N. D. & Hood, L. P4 medicine: how systems medicine will transform the healthcare sector and society. Per. Med. 10, 565–576 (2013).
doi: 10.2217/pme.13.57
Musich, S., Wang, S., Hawkins, K. & Klemes, A. The impact of personalized preventive care on health care quality, utilization, and expenditures. Popul. Health Manag. 19, 389–397. (2016).
doi: 10.1089/pop.2015.0171
Ezkurdia, I. et al. Multiple evidence strands suggest that there may be as few as 19,000 human protein-coding genes. Hum. Mol. Genet. 23, 5866–5878 (2014).
doi: 10.1093/hmg/ddu309
Lin, H. et al. Discovery of a cytokine and its receptor by functional screening of the extracellular proteome. Science 320, 807–811 (2008).
doi: 10.1126/science.1154370
Harrell, F. E. Jr. Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis (Springer, 2015).
Pencina, Michael J. et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Stat. Med. 27, 157–172 (2008).
doi: 10.1002/sim.2929
Fielding, C. M. & Angulo, P. Hepatic steatosis and steatohepatitis: are they really two distinct entities? Curr. Hepatol. Rep. 13, 151–158 (2014).
doi: 10.1007/s11901-014-0227-5
Yki-Jarvinen, H. Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol. 2, 901–910. (2014).
doi: 10.1016/S2213-8587(14)70032-4
Shuster, A., Patlas, M., Pinthus, J. H. & Mourtzakis, M. The clinical importance of visceral adiposity: a critical review of methods for visceral adipose tissue analysis. Br. J. Radiol. 85, 1–10 (2012).
doi: 10.1259/bjr/38447238
Ross, R. et al. Importance of assessing cardiorespiratory fitness in clinical practice: a case for fitness as a clinical vital sign: a scientific statement from the American Heart Association. Circulation 134, e653–e699 (2016).
doi: 10.1161/CIR.0000000000000461
de Souza de Silva, C. G. et al. Association between cardiorespiratory fitness, obesity, and health care costs: The Veterans Exercise Testing Study. Int. J. Obes. (Lond.) https://doi.org/10.1038/s41366-018-0257-0 (2018).
doi: 10.1038/s41366-018-0257-0
Hobbs, F. D., Jukema, J. W., Da Silva, P. M., McCormack, T. & Catapano, A. L. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. QJM 103, 727–739 (2010).
doi: 10.1093/qjmed/hcq122
Ostroff, R. M. et al. Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer. PLoS ONE 5, e15003 (2010).
doi: 10.1371/journal.pone.0015003
Ostroff, R. M. et al. Early detection of malignant pleural mesothelioma in asbestos-exposed individuals with a noninvasive proteomics-based surveillance tool. PLoS ONE 7, e46091 (2012).
doi: 10.1371/journal.pone.0046091
Usher-Smith, J. A., Sharp, S. J. & Griffin, S. J. The spectrum effect in tests for risk prediction, screening, and diagnosis. BMJ 353, i3139 (2016).
doi: 10.1136/bmj.i3139
Ganna, A. et al. Risk prediction measures for case-cohort and nested case-control designs: an application to cardiovascular disease. Am. J. Epidemiol. 175, 715–724 (2012).
doi: 10.1093/aje/kwr374
Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann. Intern. Med. 150, 604–612 (2009).
doi: 10.7326/0003-4819-150-9-200905050-00006
Zou, H. & Hastie, T. Regularization and variable selection via the elastic net. J. R. Stat. Soc. B 67, 301–320 (2005).
doi: 10.1111/j.1467-9868.2005.00503.x
Tibshirani, R. Regression shrinkage and selection via the LASSO. J. R. Stat. Soc. B 58, 267–288 (1996).